Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
39 hedge funds and large institutions have $151M invested in Global Cord Blood Corporation in 2019 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 6 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 6
10% more capital invested
Capital invested by funds: $138M → $151M (+$13.1M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
3% less funds holding
Funds holding: 40 → 39 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$1.4M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$1.01M |
| 3 |
SG Americas Securities
New York
|
+$713K |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$440K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$433K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JCM
Jayhawk Capital Management
Shawnee,
Kansas
|
-$3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$387K |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$252K |
| 4 |
PI
PEAK6 Investments
Chicago,
Illinois
|
-$208K |
| 5 |
VF
Virtu Financial
New York
|
-$87K |
CO Hedge Fund Activity: Q1 2019 in Review
39 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q1 2019, worth a combined $151M — up 9.5% from $138M a quarter earlier.
Fund positioning in CO was balanced in Q1 2019: 6 funds opened new positions, 6 closed out, 15 added to existing stakes and 6 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.4M. The largest seller was Jayhawk Capital Management, cutting an estimated $3M.
- 39 institutional investors held Global Cord Blood Corporation (CO) as of Q1 2019, down from 40 in Q4 2018.
- Funds reported $151M of Global Cord Blood Corporation stock for Q1 2019, up 9.5% quarter-over-quarter.
- 6 funds opened new Global Cord Blood Corporation positions in Q1 2019 and 6 closed out, a net change of 0 holders.
- The largest Global Cord Blood Corporation buyer in Q1 2019 was Renaissance Technologies, an estimated $1.4M added.
- The largest Global Cord Blood Corporation seller in Q1 2019 was Jayhawk Capital Management, an estimated $3M sold.
Based on aggregated 13F filings for Q1 2019.